Chief Executive Officer

Other news to note for April 29, 2025

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Anthem Blue Cross/Blue Shield

Neurostimulation Devices Market Set to Reach US$ 11.83 Billion by 2030, Driven by Rising Neurological Disorders and Technological Advancements - The Insight Partners

From The Philippines To Argentina, These Four Countries Saw Startup Funding Rise

Associate Therapy Manager

Mainstay Medical is a medical device company focused on marketing an innovative implantable neurostimulation system for chronic low back pain. The Associate Therapy Manager is responsible for driving therapy adoption among Spine Surgeons and building a sustainable business through key customer relationships and effective sales strategies.

Sign up with Google

Sign in with Google